Ignite Creation Date:
2024-10-26 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06631079
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-10-02
Brief Title:
Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Anti-PD-1PD-L1 Therapy in Patients With Solid Tumors
Sponsor:
Organization:
None